Articles

Cellular chariots

TSRI researchers link cellular cargo transport machinery to neurological disorders
Written byIlene Schneider
| 4 min read

LA JOLLA, Calif.—Motor proteins called dyneins “walk” along structures called microtubules to deliver cellular cargo, such as signaling molecules and organelles, to different parts of a cell. Without dynein, cells cannot divide and people can develop neurological diseases.

A new study, published in the journal Nature Structural & Molecular Biology, offers the first three-dimensional visualization of the dynein-dynactin complex bound to microtubules. The study was supported by the National Institutes of Health, the National Science Foundation, the Searle Scholars Program, the Pew Scholars Program and the Johns Hopkins Krieger School of Arts and Sciences.

Researchers from The Scripps Research Institute (TSRI) report that a protein called dynactin hitches two dyneins together, like a yoke locking together a pair of draft horses. According to Dr. Gabriel C. Lander, associate professor at The Scripps Research Institute (TSRI) and senior author of the study, “If you want a team of horses to move in one direction, you need to line them up. That’s exactly what dynactin is doing to dynein molecules.”

Understanding how the dynein-dynactin complex is assembled and organized provides a critical foundation to explain the underlying causes of several dynein-related neurodegenerative diseases such as spinal muscular atrophy (SMA) and Charcot-Marie-Tooth (CMT) disease. Postdoctoral research associates Danielle Grotjahn and Saikat Chowdhury elaborated on the study.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Published In

Volume 14 - Issue 4 | April 2018

April 2018

April 2018 Issue

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue